151 related articles for article (PubMed ID: 21482077)
1. Imatinib mesylate induction of ROS-dependent apoptosis in melanoma B16F0 cells.
Chang SP; Shen SC; Lee WR; Yang LL; Chen YC
J Dermatol Sci; 2011 Jun; 62(3):183-91. PubMed ID: 21482077
[TBL] [Abstract][Full Text] [Related]
2. Nilotinib induction of melanogenesis via reactive oxygen species-dependent JNK activation in B16F0 mouse melanoma cells.
Chang SP; Huang HM; Shen SC; Lee WR; Chen YC
Exp Dermatol; 2018 Dec; 27(12):1388-1394. PubMed ID: 30290020
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
4. Modulation of ROS/MAPK signaling pathways by okadaic acid leads to cell death via, mitochondrial mediated caspase-dependent mechanism.
Ravindran J; Gupta N; Agrawal M; Bala Bhaskar AS; Lakshmana Rao PV
Apoptosis; 2011 Feb; 16(2):145-61. PubMed ID: 21082355
[TBL] [Abstract][Full Text] [Related]
5. STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.
Huang DY; Chao Y; Tai MH; Yu YH; Lin WW
J Biomed Sci; 2012 Mar; 19(1):35. PubMed ID: 22462553
[TBL] [Abstract][Full Text] [Related]
6. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition.
Te Kronnie G; Timeus F; Rinaldi A; Crescenzio N; Spinelli M; Rosolen A; Ricotti E; Basso G
Int J Mol Med; 2004 Sep; 14(3):373-82. PubMed ID: 15289888
[TBL] [Abstract][Full Text] [Related]
7. The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib.
Yu C; Rahmani M; Dent P; Grant S
Exp Cell Res; 2004 May; 295(2):555-66. PubMed ID: 15093752
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571.
Kumar S; Mishra N; Raina D; Saxena S; Kufe D
Mol Pharmacol; 2003 Feb; 63(2):276-82. PubMed ID: 12527798
[TBL] [Abstract][Full Text] [Related]
9. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
[TBL] [Abstract][Full Text] [Related]
10. The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells.
Bright SA; Greene LM; Greene TF; Campiani G; Butini S; Brindisi M; Lawler M; Meegan MJ; Williams DC; Zisterer DM
Biochem Pharmacol; 2009 Feb; 77(3):310-21. PubMed ID: 19014913
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571.
Klejman A; Rushen L; Morrione A; Slupianek A; Skorski T
Oncogene; 2002 Aug; 21(38):5868-76. PubMed ID: 12185586
[TBL] [Abstract][Full Text] [Related]
12. Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
Chen J; Guo R; Yan H; Tian L; You Q; Li S; Huang R; Wu K
Basic Clin Pharmacol Toxicol; 2014 Apr; 114(4):293-304. PubMed ID: 24118820
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis induced by a new flavonoid in human hepatoma HepG2 cells involves reactive oxygen species-mediated mitochondrial dysfunction and MAPK activation.
Liu H; Xiao Y; Xiong C; Wei A; Ruan J
Eur J Pharmacol; 2011 Mar; 654(3):209-16. PubMed ID: 21241688
[TBL] [Abstract][Full Text] [Related]
14. [STI571 induces apoptosis of K562 cells through down-regulation of anti-apoptotic protein Mcl-1 and Bcl-xl expression].
Zhang BZ; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1182-5. PubMed ID: 18088462
[TBL] [Abstract][Full Text] [Related]
15. Induction of urokinase-type plasminogen activator, interleukin-8 and early growth response-1 by STI571 through activating mitogen activated protein kinase in human small cell lung cancer cells.
Yoshida C; Niiya K; Niiya M; Shibakura M; Asaumi N; Tanimoto M
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):425-33. PubMed ID: 17581316
[TBL] [Abstract][Full Text] [Related]
16. MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell lines.
Sims JT; Plattner R
Cancer Chemother Pharmacol; 2009 Aug; 64(3):629-33. PubMed ID: 19396599
[TBL] [Abstract][Full Text] [Related]
17. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
18. [The anti-tumoral effect of PI3K inhibitor and MEK inhibitor combined with STI571 on chronic myeloid leukemia cells in a bone marrow stromal cell co-culture system].
Jin L; Kato A; Tabe Y
Rinsho Ketsueki; 2006 Oct; 47(10):1364-71. PubMed ID: 17094575
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.
Yu C; Rahmani M; Almenara J; Subler M; Krystal G; Conrad D; Varticovski L; Dent P; Grant S
Cancer Res; 2003 May; 63(9):2118-26. PubMed ID: 12727828
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of STI571 inducing apoptosis of K562 cells.
Qin Y; Chen S; Chang Y; Fu J; Wang X
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):289-92. PubMed ID: 12411057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
